FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:724-727 August 18, 2005 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Windecker, S. Related Article by Dibra, A. PubMed Citation

Since the inception of percutaneous coronary intervention (PCI), restenosis leading to repeated target-lesion revascularization has been the primary weakness of the procedure and has been repeatedly referred to as its Achilles' heel. Placement of a coronary-artery stent has emerged as the technique of choice for PCI, because it provides a substantial reduction in the percentage of patients who need subsequent target-lesion revascularization — from 25 to 35 percent after balloon angioplasty alone to 10 to 15 percent after stenting. Most of the luminal loss after stent placement is clinically evident in the first six to nine months after the placement . . . [Full Text of this Article]

Source Information

From the Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington.

Related Letters:

Drug-Eluting Coronary Stents
Alarcón J. A., Arribas J. M., Ruiz V., Czupryniak L., Pawlowski M., Loba J., Bonvini R. F., Verin V., Waksman R., Wolfram R. M., Jneid H., Jang I.-K., Palacios I., Kastrati A., Dibra A., Schömig A., Windecker S., Jüni P., Meier B., Moliterno D. J.
Extract | Full Text | PDF  
N Engl J Med 2005; 353:2404-2408, Dec 1, 2005. Correspondence

This article has been cited by other articles:

• Newsome, L. T., Kutcher, M. A., Royster, R. L. (2008). Coronary Artery Stents: Part I. Evolution of Percutaneous Coronary Intervention. Anesth. Analg. 107: 552-569 [Abstract] [Full Text]  
• Martin, K. A., Merenick, B. L., Ding, M., Fetalvero, K. M., Rzucidlo, E. M., Kozul, C. D., Brown, D. J., Chiu, H. Y., Shyu, M., Drapeau, B. L., Wagner, R. J., Powell, R. J. (2007). Rapamycin Promotes Vascular Smooth Muscle Cell Differentiation through Insulin Receptor Substrate-1/Phosphatidylinositol 3-Kinase/Akt2 Feedback Signaling. J. Biol. Chem. 282: 36112-36120 [Abstract] [Full Text]  
• Weyrich, A. S., Denis, M. M., Schwertz, H., Tolley, N. D., Foulks, J., Spencer, E., Kraiss, L. W., Albertine, K. H., McIntyre, T. M., Zimmerman, G. A. (2007). mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Blood 109: 1975-1983 [Abstract] [Full Text]  
• Kandzari, D. E., Leon, M. B., Popma, J. J., Fitzgerald, P. J., O'Shaughnessy, C., Ball, M. W., Turco, M., Applegate, R. J., Gurbel, P. A., Midei, M. G., Badre, S. S., Mauri, L., Thompson, K. P., LeNarz, L. A., Kuntz, R. E., for the ENDEAVOR III Investigators, (2006). Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease: A Randomized Controlled Trial. J Am Coll Cardiol 48: 2440-2447 [Abstract] [Full Text]  
• Ashley, E. A., Ferrara, R., King, J. Y., Vailaya, A., Kuchinsky, A., He, X., Byers, B., Gerckens, U., Oblin, S., Tsalenko, A., Soito, A., Spin, J. M., Tabibiazar, R., Connolly, A. J., Simpson, J. B., Grube, E., Quertermous, T. (2006). Network Analysis of Human In-Stent Restenosis. Circulation 114: 2644-2654 [Abstract] [Full Text]  
• Dalal, A. R., D'Souza, S., Shulman, M. S. (2006). Brief review: Coronary drug-eluting stents and anesthesia: [Article de synthese court : Les tuteurs coronariens actifs et l'anesthesie]. Canadian J. Anesthesia 53: 1230-1243 [Abstract] [Full Text]  
• Scheller, B., Hehrlein, C., Bocksch, W., Rutsch, W., Haghi, D., Dietz, U., Bohm, M., Speck, U. (2006). Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon Catheter. NEJM 355: 2113-2124 [Abstract] [Full Text]  
• Saia, F., Piovaccari, G., Manari, A., Santarelli, A., Benassi, A., Aurier, E., Sangiorgio, P., Tarantino, F., Geraci, G., Vecchi, G., Guastaroba, P., Grilli, R., Marzocchi, A. (2006). Clinical Outcomes for Sirolimus-Eluting Stents and Polymer-Coated Paclitaxel-Eluting Stents in Daily Practice: Results From a Large Multicenter Registry. J Am Coll Cardiol 48: 1312-1318 [Abstract] [Full Text]  
• Vaitkus, P. T. (2006). Common Sense, Dollars and Cents, and Drug-Eluting Stents. J Am Coll Cardiol 48: 268-269 [Full Text]  
• Boccara, F, Teiger, E, Cohen, A (2006). Role of drug eluting stents in diabetic patients. Heart 92: 579-581 [Abstract] [Full Text]  
• Alarcon, J. A., Arribas, J. M., Ruiz, V., Czupryniak, L., Pawlowski, M., Loba, J., Bonvini, R. F., Verin, V., Waksman, R., Wolfram, R. M., Jneid, H., Jang, I.-K., Palacios, I., Kastrati, A., Dibra, A., Schomig, A., Windecker, S., Juni, P., Meier, B., Moliterno, D. J. (2005). Drug-eluting coronary stents.. NEJM 353: 2404-2408 [Full Text]  
• (2005). Battle of the Drug-Eluting Stents. Journal Watch Cardiology 2005: 1-1 [Full Text]